Figure 1.
HPV, human papillomavirus; CIN, cervical intraepithelial neoplasia; cryo, cryotherapy; ASCUS, atypical squamous cells of undetermined significance; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion.
Table 1.
Odds ratio (OR) and 95% confidence intervals (CI) for residual disease six months after cryotherapy (cryo) for CIN2/3 by selected pre-treatment characteristics.1Kenya, 79 HIV-positive women.
Table 2.
Presence of hrHPV after cryotherapy (cryo) by type of pre-cryo sample in women who were hrHPV-positive before cryotherapy.
Table 3.
Crude odds ratio (OR) and 95% confidence intervals (CI) for residual disease six months after cryotherapy (cryo) for CIN2/3 by persistence of hrHPV infections detected in pre-cryo cells or biopsies.
Table 4.
Performance of hrHPV testing for the detection of CIN2/3 six months after cryotherapy.